| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |